81 related articles for article (PubMed ID: 10359210)
21. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
Sakurai F; Terada T; Maruyama M; Watanabe Y; Yamashita F; Takakura Y; Hashida M
Cancer Gene Ther; 2003 Sep; 10(9):661-8. PubMed ID: 12944985
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors.
Indraccolo S; Moserle L; Tisato V; Gola E; Minuzzo S; Roni V; Persano L; Chieco-Bianchi L; Amadori A
Gene Ther; 2006 Jun; 13(12):953-65. PubMed ID: 16511522
[TBL] [Abstract][Full Text] [Related]
23. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
[TBL] [Abstract][Full Text] [Related]
24. Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response.
Rozera C; Carlei D; Lollini PL; De Giovanni C; Musiani P; Di Carlo E; Belardelli F; Ferrantini M
Am J Pathol; 1999 Apr; 154(4):1211-22. PubMed ID: 10233859
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
26. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
Shiau AL; Lin CY; Tzai TS; Wu CL
Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496
[TBL] [Abstract][Full Text] [Related]
27. Retroviral-mediated transfer of genes encoding interleukin-2 and interleukin-12 into fibroblasts increases host antitumor responsiveness.
Govaerts AS; Guillaume T; André M; Bayat B; Feyens AM; Hawley TS; Fong AZ; Hawley RG; Symann M
Cancer Gene Ther; 1999; 6(5):447-55. PubMed ID: 10505855
[TBL] [Abstract][Full Text] [Related]
28. Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma.
Dickson PV; Hamner JB; Burger RA; Garcia E; Ouma AA; Kim SU; Ng CY; Gray JT; Aboody KS; Danks MK; Davidoff AM
J Pediatr Surg; 2007 Jan; 42(1):48-53. PubMed ID: 17208540
[TBL] [Abstract][Full Text] [Related]
29. In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.
Duguay D; Mercier F; Stagg J; Martineau D; Bramson J; Servant M; Lin R; Galipeau J; Hiscott J
Cancer Res; 2002 Sep; 62(18):5148-52. PubMed ID: 12234977
[TBL] [Abstract][Full Text] [Related]
30. Chronopharmacology of antitumor effect induced by interferon-beta in tumor-bearing mice.
Takane H; Ohdo S; Yamada T; Yukawa E; Higuchi S
J Pharmacol Exp Ther; 2000 Aug; 294(2):746-52. PubMed ID: 10900256
[TBL] [Abstract][Full Text] [Related]
31. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M
J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088
[TBL] [Abstract][Full Text] [Related]
33. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
Xiang J; Chen Y; Moyana T
Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
[TBL] [Abstract][Full Text] [Related]
35. Prospects for cytokine and chemokine biotherapy.
Oppenheim JJ; Murphy WJ; Chertox O; Schirrmacher V; Wang JM
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2682-6. PubMed ID: 10068274
[TBL] [Abstract][Full Text] [Related]
36. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.
Ferrantini M; Capone I; Belardelli F
Biochimie; 2007; 89(6-7):884-93. PubMed ID: 17532550
[TBL] [Abstract][Full Text] [Related]
37. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM
Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073
[TBL] [Abstract][Full Text] [Related]
38. Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.
Kruklitis RJ; Singhal S; Delong P; Kapoor V; Sterman DH; Kaiser LR; Albelda SM
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):123-30. PubMed ID: 14752422
[TBL] [Abstract][Full Text] [Related]
39. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
Yang X; Chu Y; Wang Y; Zhang R; Xiong S
J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
[TBL] [Abstract][Full Text] [Related]
40. Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer.
Noguchi M; Imaizumi K; Kawabe T; Wakayama H; Horio Y; Sekido Y; Hara T; Hashimoto N; Takahashi M; Shimokata K; Hasegawa Y
Cancer Gene Ther; 2001 Jun; 8(6):421-9. PubMed ID: 11498762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
